Research Output per year
Fingerprint Dive into the research topics where Jorge Eduardo Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
THERAPY OF CML
Cortes, J. E., Kurzrock, R., Ming-Sheng, L., Reading, C., Emerson, S., Liang, J., Deisseroth, A., Feinberg, A., Siciliano, M., Kantarjian, H., Talpaz, M., Andreeff, M., Kornblau, S., Thall, P., Issa, J. P., Estrov, Z., Arlinghaus, R. B., Deininger, M., Champlin, R., Shpall, E., Austin, D., Claxton, D., Belmont, J., Reisner, Y. & Issa, K.
Project: Research project
Research Output
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia
Kolitz, J. E., Strickland, S. A., Cortes, J. E., Hogge, D., Lancet, J. E., Goldberg, S. L., Villa, K. F., Ryan, R. J., Chiarella, M., Louie, A. C., Ritchie, E. K. & Stuart, R. K., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 631-640 10 p.Research output: Contribution to journal › Article
Open Access
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia
Sasaki, K., Kanagal-Shamanna, R., Montalban-Bravo, G., Assi, R., Jabbour, E., Ravandi, F., Kadia, T., Pierce, S., Takahashi, K., Nogueras Gonzalez, G., Patel, K., Soltysiak, K. A., Cortes, J., Kantarjian, H. M. & Garcia-Manero, G., Feb 15 2020, In : Cancer. 126, 4, p. 765-774 10 p.Research output: Contribution to journal › Article
1
Scopus
citations
Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia
Naqvi, K., Jabbour, E., Skinner, J., Anderson, K., Dellasala, S., Yilmaz, M., Ferrajoli, A., Bose, P., Thompson, P., Alvarado, Y., Jain, N., Takahashi, K., Burger, J., Estrov, Z., Borthakur, G., Pemmaraju, N., Paul, S., Cortes, J. & Kantarjian, H. M., Jan 1 2020, In : Cancer. 126, 1, p. 67-75 9 p.Research output: Contribution to journal › Article
Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia
Masarova, L., Cortes, J. E., Patel, K. P., O’Brien, S., Nogueras-Gonzalez, G. M., Konopleva, M., Verstovsek, S., Garcia-Manero, G., Ferrajoli, A., Kadia, T. M., Ravandi-Kashani, F., Borthakur, G., DellaSala, S., Estrov, Z., Jabbour, E. J. & Kantarjian, H. M., Jan 1 2020, (Accepted/In press) In : Cancer. 126, 7, p. 1448-1459 12 p.Research output: Contribution to journal › Article
Long-term results of frontline dasatinib in chronic myeloid leukemia
Maiti, A., Cortes, J. E., Patel, K. P., Masarova, L., Borthakur, G., Ravandi, F., Verstovsek, S., Ferrajoli, A., Estrov, Z., Garcia-Manero, G., Kadia, T. M., Nogueras-González, G. M., Skinner, J., Poku, R., DellaSala, S., Luthra, R., Jabbour, E. J., O’Brien, S. & Kantarjian, H. M., Jan 1 2020, (Accepted/In press) In : Cancer. 126, 7, p. 1502-1511 10 p.Research output: Contribution to journal › Article